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Mutations in WDR45 gene, coding for a beta-propeller protein, have been found in
patients affected by Neurodegeneration with Brain Iron Accumulation, NBIA5 (also
known as BPAN). BPAN is a movement disorder with Non Transferrin Bound Iron
(NTBI) accumulation in the basal ganglia as common hallmark between NBIA classes
(Hayflick et al., 2013). WDR45 has been predicted to have a role in autophagy, while the
impairment of iron metabolism in the different NBIA subclasses has not currently been
clarified. We found the up-regulation of the ferrous iron transporter (−)IRE/Divalent Metal
Transporter1 and down-regulation of Transferrin receptor in the fibroblasts of two BPAN
affected patients with splicing mutations 235+1G>A (BPAN1) and 517_5191Val 173
(BPAN2). The BPAN patients showed a concomitant increase of intracellular ferrous iron
after starvation. An altered pattern of iron transporters with iron overload is highlighted
in BPAN human fibroblasts, supporting for a role of DMT1 in NBIA. We here present
a novel element, about iron accumulation, to the existing knowledge in field of NBIA.
Attention is focused to a starvation-dependent iron overload, possibly accounting for
iron accumulation in the basal ganglia. Further investigation could clarify iron regulation
in BPAN.
Keywords: Divalent metal transporter 1 (DMT1), iron, neurodegeneration, NBIA, WDR45, beta-propeller
associated neurodegeneration (BPAN)
INTRODUCTION
De novo mutations in WDR45 gene on chromosome Xp11 have been found in patients with
BPAN (Hayflick et al., 2013), a movement disorder with iron accumulation in the basal ganglia
characterized by early childhood psychomotor retardation remaining static until the third decade
of life, after which time affected individuals develop progressive dystonia-Parkinsonism and
dementia (Haack et al., 2012, 2013; Lunt et al., 2013; Saitsu et al., 2013; Schneider et al., 2013).
BPAN is always sporadic, with a female preponderance indicative of X-linked dominant inheritance
with lethality in males. The identified allelic mutations of WDR45 produce loss of function and
impairment of autophagy as principal knowledge of BPAN neurodegeneration, because the role of
iron metabolism and cerebral iron deposition in the disease is currently not clarified.
Abbreviations: (−)IRE, without Iron Responsive Element; BPAN, Beta-propeller protein associated neurodegeneration;
DMT1, Divalent metal transporter 1; NBIA5: Neurodegeneration with iron accumulation, type 5; TfR, Transferrin Receptor.
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WDR45 is a member of the WD40 repeat protein family.
WD40 domains are units of conserved 40 aminoacids with a
consensus repeat of tryptophan-aspartic acid (WD) residues for
interaction with phospholipids. WD40 proteins have a highly
symmetrical, seven-bladed, beta-propeller platform structure,
coordinating protein–protein interactions. In particular, WDR45
protein that is regulated by the induction of autophagy, has been
proposed as a biomarker of autophagosome formation (Tsuyuki
et al., 2014). Autophagy is a cellular degradation system for long-
lived proteins and organelles, activated during nutrient starvation
with the contribution of the ATG genes, yeast autophagy-
related genes. Furthermore, the WIPI4/WDR45 gene of the
WIPI (WD repeat protein interacting with phosphoinositides)
family, is a mammalian ortholog of the yeast autophagy gene
ATG18, particularly induced during autophagy. Although the
mechanistic relationship between WDR45 deficiency and the
causes of BPAN neurodegeneration are unknown, a clear pattern
of clinical imaging and natural history data leads to the
identification of the specific phenotype of patients. This NBIA
disorder was indeed called ‘beta-propeller protein-associated
neurodegeneration’ (BPAN) (Haack et al., 2012).
Recently, we found iron and DMT1 accumulation in the
substantia nigra (SN) of a mice model of neurodegeneration with
Parkinsonism, the NF-kB/c-rel knockout mice (Baiguera et al.,
2012), according to previous findings in Parkinson’s patients
(Salazar et al., 2008), and during the early phase of brain
ischemia (Ingrassia et al., 2012). Therefore, we hypothesized a
relationship between de novo mutations in WDR45 gene and
the isoform without Iron Response Element (IRE) of ferrous
iron transporter DMT1, (−)IRE/DMT1. We based this work on
the well-acknowledged evidence that human primary fibroblasts
efficiently reflect molecular and functional changes associated
to neurodegenerative pathologies (Campanella et al., 2012;
Zanellati et al., 2015). To this purpose, we studied the pattern
of iron transporters and ferrous iron in primary fibroblasts of
two BPAN patients to assess whether the impairment of iron
transport could account for its accumulation. DMT1 function
is associated to a complex structure and its regulation is finely
tuned by the expression of four different isoforms, generated
by two alternative splicings (Hubert and Hentze, 2002; Garrick
et al., 2006; Mackenzie et al., 2007). The first splicing produces
two different promoter regions, 1A and 1B. The 1A splicing
is responsive to hypoxia in rat PC12 cells (Lis et al., 2005)
and HIF-2 alpha in Caco-2/TC7 cells (Mastrogiannaki et al.,
2009), while the 1B isoform is responsive to NF-kB in P19
mouse embryonic carcinoma cells and mouse primary cortical
neurons (Paradkar and Roth, 2006a,b; Ingrassia et al., 2012).
1B isoform is also responsive to HIF-1 alpha in HepG2 cells
(Wang et al., 2010; Qian et al., 2011). The second splicing implies
that both 1A and 1B isoforms may have or not an IRE at the
opposite 3’ untranslated region. This mechanism is sensitive
to feedback regulation by intracellular iron levels (Hentze and
Kühn, 1996; Pantopoulos, 2004; Recalcati et al., 2010; Sanchez
et al., 2011; Wilkinson and Pantopoulos, 2014). In particular,
the mRNA analysis of 1B/(+)IRE isoform shows the predicted
down-regulation in conditions of intracellular iron overload, as
well as TfR, while the 1B/(−)IRE isoform can be regulated by
iron-independent mechanism (Hubert and Hentze, 2002). While
the specific expression of 1B/(+)IRE isoform and 1A/(+)IRE is
also shown in primary rat hippocampal neurons and astrocytes,
respectively (Pelizzoni et al., 2012, 2013), only 1A/(+)IRE over-
expression showed competence for ferrous iron uptake. Indeed,
intracellular iron overload leads to the canonical IRE/IRP post-
transcriptional control with down-regulation of both TfR and
(+)IRE/DMT1 isoform, like several mRNA encoding proteins
of iron, oxygen and energy metabolism (Hubert and Hentze,
2002; Pantopoulos, 2004; Wilkinson and Pantopoulos, 2014). In
this respect, while (+)IRE/DMT1 isoform shouldn’t contribute
to the increased uptake of ferrous iron during iron overload,
(−)IRE/DMT1 isoform is not influenced by intracellular iron
perturbation. Conversely, (−)IRE/DMT1 could be up-regulated
at transcriptional (Paradkar and Roth, 2006a,b; Ingrassia et al.,
2012) or post-translational level, via proteasome impairment
(Garrick et al., 2012). Importantly, not only (−)IRE/DMT1 is
independent from post-transcriptional iron regulation with the
role in Non Transferrin Bound Iron (NTBI) internalization,
but it is also involved in the life-sustaining TfR cycle (Tabuchi
et al., 2010). In fact, it is localized on early endosomes,
with TfR co-localization during recycling. Moreover, a different
subcellular distribution of DMT1 is reported with cell membrane,
cytoplasmic and nuclear localization (Roth et al., 2000; Lis
et al., 2004). Since iron is essential for cellular homeostasis, its
intracellular level and transport has to be tightly controlled due
to the damaging role in the Haber–Weiss/Fenton autocatalytic
reactions, thus supporting for a role of (−)IRE/DMT1 in NBIA.
Indeed, (−)IRE/DMT1 could play a peculiar role in the increase
of the ferrous iron in BPAN and, more generally, in the other
forms NBIA. Iron accumulation in the basal ganglia represents
a common hallmark between the different classes of NBIA
(Gregory and Hayflick, 2013; Rouault, 2013; Levi and Finazzi,
2014; Hogarth, 2015; Nishioka et al., 2015; Arber et al., 2016),
and is a central element for a more innovative therapy (Zorzi
and Nardocci, 2013). In BPAN patients, where the impairment
of autophagy is the principal peculiarity, due to mutations of
WDR45 gene, involved in autophagosome maturation (Arber
et al., 2016 and references therein), besides iron accumulation,
we highlight a possible relationship between the impairment
of iron homeostasis and the altered pattern of DMT1 and TfR
with a consequent ferrous iron overload. Since no evidence up
to now is present about a derangement of iron metabolism
in BPAN patients, we analyzed primary fibroblasts of BPAN
patients to assess whether they could show a parallel pattern
to cerebral iron overload. We thus hypothesized that, in BPAN
patients, (−)IRE/DMT1, the isoform unresponsive to IRE/IRP
post-transcriptional regulation, could be up-regulated, as a
possible mediator of NTBI, at least in proliferating cells like
fibroblasts.
MATERIALS AND METHODS
Cell Culture and Treatment
Human primary fibroblasts from two BPAN affected patients
and healthy subjects of the same age, gender and subcultures,
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derived from skin biopsy, were kindly provided from the “Cell
line and DNA Bank of Genetic Movement Disorders and
Mitochondrial Diseases” of the Telethon Network of Genetic
Biobank and were cultured in DMEM supplemented with
10% FBS, L-glutamine and antibiotic solution in a 5% CO2
incubator. After plating of 2 × 104 cells/cm2 in 10 cm2 petri
dishes (Corning) and overnight growth in complete DMEM,
the cells were exposed or not to starvation for 2 h, in
DMEM, L-Glutamine and antibiotic solution, without FBS, in
a 5% CO2 incubator and then collected for cellular extracts
preparation.
Immunoblotting
Total protein extracts from human fibroblasts were prepared
for Immunoblot analyses. Cells were lysed with lysis buffer
(50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1%
Triton X-100, Complete EDTA-free protease inhibitor cocktail
and Phospho stop reagent, Roche). Cell lysates were clarified by
centrifugation at 12,000g for 20 min and analyzed by SDS-PAGE
and immunoblotting, against the Protein Molecular Weight
Marker Odyssey (LI-COR). The following antibodies were used:
rabbit anti-rat DMT1(−)IRE (Alpha Diagnostic International,
NRAMP23-A, affinity pure IgG), mouse anti-human TfR
(Invitrogen, 13–6800), mouse anti-GAPDH (Millipore, AB2302).
Signal detection and densitometric normalization of protein
expression were performed on three experiments in triplicate, by
LI-COR/Odyssey Infra-red analysis.
Turnbull’s Staining
Turnbull’s staining for ferrous iron was performed according to
Park et al. (2015). Briefly, cells were plated onto poly-L-lysine-
coated coverslips at 2 × 104 cells/cm2 in 2 cm2 multi-wells
petri dishes (Corning) and overnight grown. After 2 h starvation
in DMEM serum free with L-Glutamine, the fibroblasts were
washed in phosphate buffer saline, fixed in 4% paraformaldehyde
30 min and washed in phosphate buffer saline. Then, incubation
with 2% potassium ferricyanide in 2%HCl, 30 min was performed
followed by three washes in distilled water. Iron staining was
observed under Olympus inverted microscope in phase contrast
using a 20X PanApoN lens. Normalization was based on cellular
number. Quantification was performed by ImageJ (National
Institute of Health) on three experiments in triplicate, which are
normalized by size of the selected area scale setting in calibrated
units of the analyzed cellular field.
Statistical Analysis
Experimental differences between the groups were calculated
as the means ± SE and subjected to the analysis of variance
(ANOVA) with Bonferroni post hoc test, using Graph Pad Prism
software (version 4.0). All differences were considered statistically
significant at the P-value<0,05.
RESULTS
We investigated (−)IRE/DMT1 and TfR expression in human
fibroblasts of two BPAN affected patients, BPAN1 and BPAN2,
FIGURE 1 | (−)IRE/DMT1 isoform and TfR expression in human
fibroblast of BPAN patients. (A) Representative western blots of
(−)IRE/DMT1 and TfR in human fibroblasts of BPAN patients respect to health
controls. (B) Densitometric analysis shows TfR protein level respect to
controls (∗∗∗p < 0,001 and ##p < 0,01, BPAN 1 and BPAN2, respectively, vs.
Controls) and (C) (−)IRE/DMT1 protein level in BPAN1 and BPAN2 respect to
control fibroblasts, CTR1 and CTR2 (∗∗∗p < 0,001 BPAN1 and ###p < 0,001
BPAN2, 60 and 90 kDa components, vs. Controls). As housekeeping internal
control α-tubulin was evaluated.
respect to fibroblasts of control healthy subjects, CTR1 and
CTR2. (−)IRE/DMT1, the isoform unresponsive to IRE/IRP-
dependent post-transcriptional regulation, and TfR showed a
significantly altered pattern of expression. We found significant
up-regulation, between two and fourfold, of (−)IRE/DMT1
in fibroblasts of BPAN1 and BPAN2 patients, compared to
CTR1 and CTR2 (∗∗∗p < 0,001 BPAN1 and ###p < 0,001
BPAN2 vs. CTR1 and CTR1) as showed in a representative
immunoreactivity experiment (Figures 1A,C). Interestingly,
both (−)IRE/DMT1 glycosylated components were up-regulated:
the 60 kDa component, the one early glycosylated, was more
significantly up-regulated than the 90 kDa fully glycosylated
one. Although we performed immunoreactivity experiments
with an isoform-specific antibody against (−)IRE/DMT1, we
then verified it subjecting BPAN and Control fibroblasts
to the same analysis at different passages of growth, as
shown in Supplemental Figures 1A,B. We found reproducible
levels of detection, according to the recognized variability of
immunoreactivity against the 60 and 90 kDa differentially
glycosylated components. We conversely found the concomitant
down-regulation of TfR in the fibroblasts of BPAN patients
(∗∗∗p< 0,001 and ##p< 0,01 respect to Controls; Figures 1A,B),
in accordance with the canonical IRE/IRP post-transcriptional
regulation during intracellular iron overload. Ferrous iron was
significantly increased, after 2 h of starvation, as shown by
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FIGURE 2 | Ferrous iron in BPAN fibroblasts under starvation, respect to (−)IRE/DMT1 and TfR. (A) Iron enrichment was evaluated by Turnbull’s staining,
after 2 h starvation of BPAN and control fibroblasts, and showed in a representative detection. (B) Staining intensity was determined by ImageJ as saturation signal
of the whole cellular field normalized for cellular density. Turnbull’s staining is showed as the percentage of the Relative Units signal of BPAN vs. Controls, normalized
by size of the selected area scale setting in calibrated units of the analyzed cellular field (∗∗p < 0,01 BPAN fibroblasts respect to Controls). (C) Representative
western blot of (−)IRE/DMT1 and TfR in human fibroblast of BPAN patients under starvation, respect to starved controls. (D,E) Densitometric analysis after starvation
shows the 90 kDa isoform of (−)IRE/DMT1 and TfR protein level in BPAN1 and BPAN2, respect to control fibroblasts (∗∗p < 0,001, ∗p < 0,01 BPAN 1 and BPAN2
under starvation vs. relative Controls). As housekeeping internal control GAPDH was evaluated.
Turnbull’s staining, in human fibroblasts from BPAN1 and
BPAN2 affected patients, with respect to control subjects CTR1
and CTR2, (∗∗p < 0,01 vs. Controls; Figures 2A,B). No
significant differences were present in untreated fibroblasts (data
not shown). Concomitant to the increase of ferrous iron in
BPAN fibroblasts, after starvation we found the up-regulation
of (−)IRE/DMT1 protein compared to relative basal levels
in BPAN patients (∗∗p < 0,001 and ∗p < 0,01: BPAN1 and
BPAN2, respectively, vs. relative Controls; Figures 2C,D). On
the other hand, TfR appears down-regulated under starvation
in BPAN fibroblasts extracts in respect to the relative basal
levels (∗∗p < 0,001: BPAN1 and BPAN2 vs. relative Controls;
Figures 2C,E).
DISCUSSION
As expected, we found the up-regulation of (−)IRE/DMT1 with
down-regulation of TfR in the fibroblasts of BPAN patients
respect to health controls (Figures 1A–C) in accordance with
an intracellular milieu of iron overload. In particular, the early
glycosylated 60 kDa component of DMT1 (Tabuchi et al.,
2002) was more significantly up-regulated in these patients,
supporting for a rapid positive feedback of the early glycosylated
product, possibly as a downstream effect of the known response
of endoplasmic reticulum to the impairment of autophagy
(Khaminets et al., 2015). Moreover, a significant increase of
Turnbull’s staining for intracellular ferrous iron was present in
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BPAN fibroblasts under starvation (Figures 2A,B). As nutrient
deprivation physiologically induces autophagy, we could infer
that this treatment in BPAN fibroblasts, where autophagy is
impaired, could lead to reduced lysosomal degradation with
accumulation of (−)IRE/DMT1 and the consequent increase of
ferrous iron. It is in fact well acknowledged that, under starvation,
autophagy determines degradation of unneeded proteins in
order to activate anabolic homeostasis, as a consequence of the
increased intracellular pool of amino acids (Mizushima et al.,
2004; Chen et al., 2014; Kaur and Debnath, 2015). In this respect,
autophagy not only sustains the turnover of cellular components,
but also the regulation of metabolism, membrane transport
and host defenses (Boya et al., 2013). Indeed, compromised
autophagy in BPAN cells could affect the removal of toxic
proteins, like the ferrous iron transporter, thus highlighting a
pharmacological potential target (Rubinsztein et al., 2015). In
fact, during starvation, when autophagy has an essential role in
the balance of anabolic/catabolic homeostasis and its impairment
could be detrimental, we observed the significant increase
of Turnbull’s staining for ferrous iron in BPAN fibroblasts
respect to controls (Figures 2A,B). Concomitantly, we found
the up-regulation of (−)IRE/DMT1 in respect to relative basal
level (Figures 2C,D), in the presence of a significant down-
regulation of TfR, during starvation (Figures 2C,E). These
evidences support a significant increase in the transport and
recycling of ferrous iron, compared to the ferric component,
with possible impairment of the life sustaining TfR cycle
and the intracellular redox potential in relationship with the
Haber–Weiss and Fenton reaction. Moreover, the starvation-
dependent TfR down-regulation reflects the IRE-IRP post-
translational regulation, due to concomitant ferrous iron up-
regulation, as shown by Turnbull’s staining. While this work
was in progress, DMT1 up-regulation was described in the
brain of PLAG26 knockout mouse model (Beck et al., 2015),
a different NBIA subclass, as a first evidence focusing the
attention to the ferrous iron transporter. Interestingly, Beck
et al. (2015) show the up-regulation of (+)IRE/DMT1 in
PLAG26 knockout mice model, in the central nervous system,
as well as the concomitant TfR up-regulation with cerebral
iron overload. This is in line with findings on a different
form of neurodegeneration with iron overload as in Parkinson
disease (Salazar et al., 2008), where, in the SN of post-mortem
patients, iron levels were increased with (+)IRE/DMT1 up-
regulation. Conversely, the different pattern of expression we
showed in BPAN fibroblasts, with down-regulation of TfR,
represents a condition of iron overload, according to IRE-
IRP regulation, confirmed by ferrous iron staining. In this
cellular contest, concomitant down-regulation of (+)IRE/DMT1
is also expected. Although in apparent opposition with respect
to the evidences in PLAG26 knockout mice and Parkinson’s
patients, the results we reported in primary fibroblasts could
account for the evaluation of proliferating vs. post-mitotic
cell types. The significant findings we obtained in BPAN
fibroblasts highlight the status of iron transporters, with up-
regulation of (−)IRE/DMT1 associated to increased uptake of
ferrous iron. Furthermore, the up-regulation of (−)IRE/DMT1
in BPAN fibroblasts could account for a downstream impairment
of proteasome degradation, possibly due to impairment of
autophagy, consequent to WDR45 de novo mutations. We
here highlight the underpinning relationship between altered
control of iron homeostasis and impaired autophagy in BPAN.
In fact, we found an altered pattern of both (−)IRE/DMT1
and TfR transporters in fibroblasts of BPAN patients, both
at basal level and under starvation, autophagy-dependent,
that lead us to hypothesize an imbalance in the uptake of
redox iron species. This finding was further supported by the
increased ferrous iron in BPAN fibroblasts under starvation,
as found in Turnbull’s staining. These evidences shed light
on the role of iron metabolism as an important player
downstream to autophagy impairment, under failure of specific
metabolic responses to nutrient deprivation, due to WDR45
mutations. In this respect, we need to consider that the
control of iron homeostasis is essential for healthy cellular life
and that the intracellular delivery of iron has to be tightly
regulated because of its possible damaging role in the Haber–
Weiss/Fenton autocatalytic reactions. Importantly, the altered
pattern of iron transporters with iron overload we showed in
BPAN human fibroblasts lead us to emphasize a relationship
with the general hallmark of NTBI in NBIA (Hayflick et al.,
2013).
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